Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction

Genomic and transcriptomic analysis has furthered our understanding of many tumors. Yet, thyroid cancer management is largely guided by staging and histology, with few molecular prognostic and treatment biomarkers. Here, we utilize a large cohort of 251 patients with 312 samples from two tertiary me...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, George J., Loberg, Matthew A., Gallant, Jean-Nicolas, Sheng, Quanhu, Chen, Sheau-Chiann, Lehmann, Brian D., Shaddy, Sophia M., Tigue, Megan L., Phifer, Courtney J., Wang, Li, Saab-Chalhoub, Mario W., Dehan, Lauren M., Wei, Qiang, Chen, Rui, Li, Bingshan, Kim, Christine Y., Ferguson, Donna C., Netterville, James L., Rohde, Sarah L., Solórzano, Carmen C., Bischoff, Lindsay A., Baregamian, Naira, Shaver, Aaron C., Mehrad, Mitra, Ely, Kim A., Byrne, Daniel W., Stricker, Thomas P., Murphy, Barbara A., Choe, Jennifer H., Kagohara, Luciane T., Jaffee, Elizabeth M., Huang, Eric C., Ye, Fei, Lee, Ethan, Weiss, Vivian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589635/
https://www.ncbi.nlm.nih.gov/pubmed/37868034
http://dx.doi.org/10.1016/j.xgen.2023.100409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589635/
https://www.ncbi.nlm.nih.gov/pubmed/37868034
http://dx.doi.org/10.1016/j.xgen.2023.100409

Ejemplares similares